bioRxiv Science⌕ Search

Biology subjects

Bourget, H.

Publications and source records attributed to Bourget, H..

2 recordsLinked to original sources

Mitf over-expression leads to microphthalmia and coloboma in Mitf-cre mice

The Microphthalmia associated transcription factor (Mitf) is a critical regulator of the melanocyte lineage and also plays an important role in eye development. Mitf activity in different cell types is controlled in part by ten alternative promoters and their resulting isoforms. A useful tool for melanocyte-based research, the Mitf-cre transgene was designed to express Cre recombinase from the Mitf-M promoter, which is melanocyte specific. However, Mitf-cre mice are also microphthalmic, perhaps because of insertional mutagenesis or disrupted gene expression. Here, we investigated these possibilities. We determined that the eye phenotype arises early, with Mitf-cre embryos at E13.5 exhibiting variable ocular sizes and abnormalities, but all with coloboma. Targeted locus amplification and next generation sequencing indicated that multiple copies of the transgene integrated into an intergenic region on chromosome 2, in between Spred1 and Meis2. The BAC transgene used to make Mitf-cre was larger than expected, carrying three upstream alternative promoters, Mitf-H, Mitf-D, and Mitf-B, which could express their isoforms intact off the transgene. RT-qPCR using eye tissue demonstrated a 5-fold increase in Mitf transcripts containing exon 1B1b, which is shared by Mitf-H, Mitf-D, and Mitf-B, while Spred1 and Meis2 did not differ in their expression. These findings clarify and support the usage of Mitf-cre in conditional mutagenesis in melanocytes. The specific over-expression of the Mitf-H and Mitf-D isoforms, which are preferentially expressed in the RPE, presents a unique resource for those interested in eye development and coloboma.

genetics↗

Loss of neurofibromin accelerates uveal and dermal melanoma formation driven by GNAQ

Neurofibromin is a very large and complex tumor suppressor, whose loss can synergize with other MAPK pathway mutations to promote melanoma in the skin. In this paper, we investigated whether NF1 loss has a role in other melanomas, such as those that form in the dermis or eye (uveal tract). We found that heterozygous 17q11.2 loss that includes the NF1 locus is an uncommon, but recurrent phenomenon in human dermal and uveal melanomas described previously. We studied the effects of Nf1 haploinsufficiency in mice expressing oncogenic GNAQQ209L in melanocytes and Schwann cells of peripheral nerves using the Plp1-creERT transgene, with tamoxifen given at 5 weeks of age. Nf1 haploinsufficiency accelerated dermal and uveal melanoma formation. We studied the effects of Nf1 loss in these melanomas using RNAseq. Many of the differentially expressed genes were homologous to genes whose expression correlates with prognosis in human uveal melanoma. Of particular interest was the up-regulation of cAMP signaling and its connection to protein kinase A, which is mutant in malignant melanotic nerve sheath tumors (MMNSTs). An unexpected finding was that oncogenic GNAQ was sufficient by itself to drive peripheral nerve sheath-like neoplasms in the mice. Hence, these studies reveal new insight into both melanocyte and Schwann cell transformation.

cancer biology↗